Libre Life is the editorial content platform published by Love My Libre.
We cover diabetes medtech, CGM developments, hybrid-closed loop systems, insulin pump technology, practical sensor wear advice and commentary on developments affecting people using diabetes technology.
Our aim is to provide clear, practical and editorially independent content for readers interested in diabetes technology and real-world device use.
Libre Life is published by Love My Libre Ltd.
Love My Libre designs and sells diabetes technology accessories, including Libreband and Dexband CGM armbands.
Editorial content is created independently and reflects editorial judgement, commentary, reporting and analysis.
Commercial interests do not determine editorial conclusions.
Where products sold by Love My Libre are relevant to a topic, this may be referenced transparently.
We aim to ensure factual information is accurate at the time of publication.
Sources may include:
Technology announcements, regulatory timelines and product plans can change. Readers should check original manufacturers or healthcare providers where current clinical guidance is required.
Some Libre Life content includes editorial analysis, commentary and opinion.
Where interpretation, analysis or opinion is presented, this reflects editorial judgement rather than manufacturer or third-party endorsement.
References to FreeStyle Libre, Dexcom, Medtronic, Omnipod and other diabetes technology brands may be used for factual compatibility, commentary or reporting purposes.
Libre Life is an independent publisher.
Libreband is a registered trade mark of Love My Libre Ltd.
Love My Libre is not affiliated with Abbott, Dexcom, Insulet, Medtronic or other device manufacturers unless explicitly stated.
Trade marks remain the property of their respective owners.
Libre Life content is for general informational and editorial purposes only.
It is not medical advice, diagnosis or treatment guidance.
Readers should seek advice from appropriate healthcare professionals regarding personal medical decisions.
If a factual error is identified, we aim to review and correct it promptly where appropriate.
Material corrections may be reflected within the article.
Correction requests can be sent using the contact details below.
Articles may be published under named editorial authors.
Editorial authors may include individuals with direct familiarity with diabetes technology use, product research or sector analysis.
Editorial enquiries or correction requests:
Love My Libre Ltd
https://lovemylibre.com/pages/contact
